Good Disruption? A new entrant regardless and a new paradigm for getting drugs to patients... Hospital systems are starting their own non-profit pharmaceutical companies to control cost and supply. Everything we know about traditional “roles” and “actors” is up in the air and the idea that hospitals will only provide hospital-based services is so, well, YesterYear. Welcome to 2018! Selected Excerpt: “The idea is to directly challenge the host of industry players who have capitalized on certain markets, buying up monopolies of old, off-patent drugs and then sharply raising prices, stoking public outrage and prompting a series of Congressional hearings and federal investigations. The most notorious example is of Martin Shkreli, the former hedge fund manager who raised the price of a decades-old drug, Daraprim, to $750 a tablet in 2015, from $13.50.” …see more